Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Perucca

Showing results (81-90 of 306) with videos related to

Pageof 31
Sort By:
Neuropharmacology|December 21, 2020
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further researchValentina Franco, Meir Bialer, Emilio Perucca
The Lancet. Neurology|August 21, 2007
Development of new antiepileptic drugs: challenges, incentives, and recent advancesEmilio Perucca, Jacqueline French, Meir Bialer
The Lancet. Neurology|December 15, 2015
Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drugTorbjörn Tomson, Dina Battino, Emilio Perucca
Neurobiology of Disease|May 24, 2014
Gender issues in antiepileptic drug treatmentEmilio Perucca, Dina Battino, Torbjörn Tomson
Epilepsia|March 28, 2007
Idiosyncratic adverse reactions to antiepileptic drugsGaetano Zaccara, Diego Franciotta, Emilio Perucca
Current Opinion in Neurology|March 6, 2009
Genetic basis for idiosyncratic reactions to antiepileptic drugsDiego Franciotta, Patrick Kwan, Emilio Perucca
Neuropsychiatric Disease and Treatment|April 2, 2009
Pregabalin for the management of partial epilepsyPhilippe Ryvlin, Emilio Perucca, Sylvain Rheims
The Lancet. Neurology|May 3, 2017
The remarkable story of valproic acidTorbjörn Tomson, Dina Battino, Emilio Perucca
Epilepsia|October 29, 2011
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: reply to Costa et alSylvain Rheims, Emilio Perucca, Philippe Ryvlin
Epilepsia|October 6, 2004
Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancyTorbjörn Tomson, Emilio Perucca, Dina Battino
Pageof 31

Showing results (81-90 of 306) with videos related to

Sort By:
Pageof 31
Neuropharmacology|December 21, 2020
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further researchValentina Franco, Meir Bialer, Emilio Perucca
The Lancet. Neurology|August 21, 2007
Development of new antiepileptic drugs: challenges, incentives, and recent advancesEmilio Perucca, Jacqueline French, Meir Bialer
The Lancet. Neurology|December 15, 2015
Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drugTorbjörn Tomson, Dina Battino, Emilio Perucca
Neurobiology of Disease|May 24, 2014
Gender issues in antiepileptic drug treatmentEmilio Perucca, Dina Battino, Torbjörn Tomson
Epilepsia|March 28, 2007
Idiosyncratic adverse reactions to antiepileptic drugsGaetano Zaccara, Diego Franciotta, Emilio Perucca
Current Opinion in Neurology|March 6, 2009
Genetic basis for idiosyncratic reactions to antiepileptic drugsDiego Franciotta, Patrick Kwan, Emilio Perucca
Neuropsychiatric Disease and Treatment|April 2, 2009
Pregabalin for the management of partial epilepsyPhilippe Ryvlin, Emilio Perucca, Sylvain Rheims
The Lancet. Neurology|May 3, 2017
The remarkable story of valproic acidTorbjörn Tomson, Dina Battino, Emilio Perucca
Epilepsia|October 29, 2011
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: reply to Costa et alSylvain Rheims, Emilio Perucca, Philippe Ryvlin
Epilepsia|October 6, 2004
Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancyTorbjörn Tomson, Emilio Perucca, Dina Battino
Pageof 31